ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Role of Myosin VI in Pediatric Glioma Proliferation and Invasion | University of Pennsylvania / Monalisa Mukherjea | Young Investigator Grants | 2012 | Pennsylvania |
Epigenetic Regulation of T cell Activation and Immunotherapy | The Johns Hopkins University School of Medicine / Brian Ladle, MD, PhD | Young Investigator Grants | 2013 | Maryland |
Zebrafish Modeling of PAX3-FOXO1 Driven Rhabdomyosarcoma | University of Texas Southwestern Medical Center / Genevieve Kendall, PhD | Young Investigator Grants | 2015 | Texas |
Dissecting the Role of FOXR2 in the Oncogenesis of Diffuse Intrinsic Pontine Glioma | Dana-Farber Cancer Institute / Jessica Tsai, MD/PhD | Young Investigator Grants | 2020 | Massachusetts |
Targeting the Thymic Stromal Lymphopoeitin Receptor Signaling Axis to Reduce Relapse of High Risk Pediatric Acute Lymphoblastic Leukemia | National Cancer Institute / Christopher Chien, PhD | Young Investigator Grants | 2014 | Maryland |
Mechanisms of BRAF Activation in KIAA1549-BRAF Mutant pLGGs | Broad Institute / Sean Misek, PhD | Young Investigator Grants | 2023 | Massachusetts |
GSTM4, a novel target for treating Ewing sarcoma. | Huntsman Cancer Institute / Wen Luo | Young Investigator Grants | 2009 | Utah |
Identifying Therapeutic Targets for MiT Associated Pediatric Cancers | Yale School of Medicine / Sean Landrette | Young Investigator Grants | 2012 | Connecticut |
The Role of PTPRD as a Tumor Suppressor in Neuroblastoma Pathogenesis | Mayo Clinic / Shizhen Zhu, MD, PhD | Young Investigator Grants | 2013 | Minnesota |
Critical Contributions of CRM1 to Leukemogenesis | University of Vermont / Jessica Linda Heath, MD | Young Investigator Grants | 2015 | Vermont |